KKI-5

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

KKI 5 is a serine protease inhibitor that inhibits kallikrein and plasmin. KKI 5 may exhibit anticancer chemotherapeutic benefit and may also be used as a treatment for angioedema.

KKI 5 is a serine protease inhibitor that inhibits kallikrein and plasmin. KKI 5 may exhibit anticancer chemotherapeutic benefit and may also be used as a treatment for angioedema.(In Vitro):The KKI-5 Peptide corresponds to aa386-391 of bovine kininogen-1 that encompasses the aa388-389 kallikrein proteolytic site. The synthetic KKI-5 can attenuate breast cancer cell invasion, therefore it is investigated for its role in invasion and metastasis of cancer cells.

The KKI-5 Peptide corresponds to aa386-391 of bovine kininogen-1 that encompasses the aa388-389 kallikrein proteolytic site. The synthetic KKI-5 can attenuate breast cancer cell invasion, therefore it is investigated for its role in invasion and metastasis of cancer cells.

——

——

Others

Other Targets

Kallikrein Inhibitor

——

——

97145-43-2

773.88

C35H55N11O9

>98% (HPLC)

——

——

Sequence:Ac-Pro-Phe-Arg-Ser-Val-Gln-NH2

(-20℃)

With Ice Pack

≥ 2 years